Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Product Safety Labs
483
•Product Safety Labs•July 24, 2025

Product Safety Labs – FDA 483, Jul 24, 2025

Record Details

During an inspection conducted from July 21-24, 2025, the U.S. Food and Drug Administration (FDA) issued a Form 483 to Product Safety Labs, a nonclinical laboratory located in Dayton, NJ. The inspection revealed two significant observations indicating a need for improved adherence to established procedures and facility controls. The primary issue involved inadequate management authorization for changes to standard operating procedures (SOPs). Specifically, the SOP for "Transfer of Archived Materials" was not followed, leading to several deficiencies. These included wet tissues for two studies not being properly signed out, the inability of the archivist to locate documentation for tissue sign-out, lack of archivist access to sponsor agreements, and the discovery of unattended wet tissues in an unsecure laboratory. The second observation highlighted concerns with the facility's design and maintenance, specifically regarding its ability to prevent adverse effects on studies. Damaged contamination control floor mats, which had exceeded their manufacturer-specified lifespan, were observed throughout the facility. Furthermore, Product Safety Labs lacked a written procedure for the maintenance of these critical contamination control measures. These observations, issued under Section 704(b) of the Federal Food, Drug and Cosmetic Act, require Product Safety Labs to promptly address the identified conditions and practices. While the 483 form itself does not mandate specific actions, the firm is expected to respond to the FDA by detailing the corrective actions it has taken or plans to implement to rectify these compliance issues and ensure the integrity of their nonclinical studies.

Company
Product Safety Labs
Inspection date
July 24, 2025
Product type
drugs
Office
Atlanta District Office
Person
  • Deborah A. Greco
View Company Profile

ID · f6c96d7b-dc31-45ba-aeae-a1c68a848df4

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Product Safety Labs
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.